Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-stimulating Agent

GSK Investigational Site, The Bronx

GSK Investigational Site, Santiago de Compostela

GSK Investigational Site, Greenbelt

GSK Investigational Site, Kiel

GSK Investigational Site, Lleida

GSK Investigational Site, Madrid

GSK Investigational Site, Madrid

GSK Investigational Site, Madrid

GSK Investigational Site, San Sebastián de los Reyes

GSK Investigational Site, Málaga

GSK Investigational Site, Pembroke Pines

GSK Investigational Site, Santander

GSK Investigational Site, Manises (Valencia)

GSK Investigational Site, Valladolid

GSK Investigational Site, Roseville

GSK Investigational Site, Kansas City

GSK Investigational Site, Darmstadt

GSK Investigational Site, Stuttgart

GSK Investigational Site, Villingen-Schwenningen

GSK Investigational Site, Northridge

GSK Investigational Site, San Dimas

GSK Investigational Site, Moscow

GSK Investigational Site, Mytischi

GSK Investigational Site, Yaroslavl

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Krasnodar

GSK Investigational Site, Penza

GSK Investigational Site, Omsk

GSK Investigational Site, Calgary

GSK Investigational Site, Ottawa

GSK Investigational Site, Toronto

GSK Investigational Site, Greenfield Park

GSK Investigational Site, Almería

GSK Investigational Site, Badalona

GSK Investigational Site, Barcelona

GSK Investigational Site, Granollers, Barcelona

GSK Investigational Site, L'Hospitalet de Llobregat